Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
New Horizons in the Development of Treatments for Substance Use Disorders.
Journal: The American journal of psychiatry
Published: September 01, 2026
Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity.
Journal: Journal of dual diagnosis
Published: June 11, 2026
Beyond abstinence: Redefining success in cannabis use disorder treatment.
Journal: Addiction (Abingdon, England)
Published: January 16, 2026
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial.
Journal: Journal of attention disorders
Published: July 25, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder.
Journal: Journal of substance use
Published: July 18, 2024
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.
Journal: The American journal of drug and alcohol abuse
Published: October 04, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.
Journal: Experimental and clinical psychopharmacology
Published: September 21, 2023
Neural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder.
Journal: Alcohol, clinical & experimental research
Published: August 09, 2023
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs.
Journal: The American journal on addictions
Published: March 19, 2023
Correction to "Drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder is associated with reduction in anterior insula-bed nucleus of the stria terminalis resting state functional connectivity".
Journal: Alcohol, clinical & experimental research
Published: January 03, 2022
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.
Journal: The American journal of drug and alcohol abuse
Published: June 07, 2021
Last Updated: 09/26/2026